Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

Lawsuit backed by Secretary Kennedy’s former non-profit says CDC is forcing disadvantaged kids to be vaccinated.

A pharmacy in New York City advertises the coronavirus vaccine on March 11. (Spencer Platt/Getty Images) The Centers for Disease Control and Prevention might soon limit its guidance for who should ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...

Vaccines for the flu and COVID-19 can alter the menstrual cycle, but the impact is temporary and there is no reason for vaccine hesitancy, while breast cancer deaths among women ages 20 to 49 ...

Related Articles FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots Stanford study: When measles could return if vaccination rates continue to fall Novavax says its ...